Clinical Trial Update: Prevention of Asthma With Levocetirizine 18 Month Treatment in Infants (12 - 24 Months) Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and/or House Dust Mite (HDM) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating whether 18-month levocetirizine treatment in infants with atopic dermatitis and grass pollen/house dust mite sensitization can prevent …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Atopic Dermatitis

Drugs mentioned

• Levocetirizine (Levocetirizine)

Snippet

Sponsor: UCB Pharma SA | Conditions: Dermatitis, Atopic | Phase 3 | Status: COMPLETED | Results posted: 2019-01-22